Abstract
dc:description.abstractBACKGROUND: Epilepsy during pregnancy is associated with increased odds of miscarriage, stillbirth, preterm birth, maternal mortality, offspring congenital conditions, neonatal intensive care unit admission, neonatal or infant death, and offspring neurodevelopmental disorders. Findings vary between countries and study design, and although prenatal anti-seizure medication (ASM) exposure exacerbates adverse outcomes, there is evidence of increased risk without exposure. Furthermore, prenatal ASM prescribing is increasing, and there is limited population-based data specific to the United Kingdom (UK), emphasising the need to address the priorities outlined by the UK Epilepsy Priority Setting Partnership regarding epilepsy in pregnancy and prenatal exposure to ASM. This thesis aims to investigate the association between maternal epilepsy and 1) perinatal (maternal, foetal, and neonatal) outcomes, 2) offspring (neurodevelopmental, educational, and adulthood socioeconomic) outcomes, and 3) conduct an exploration of the role of prenatal ASM exposure. METHODS: Two systematic reviews and meta-analyses of observational studies were conducted concerning 1) perinatal outcomes in Chapter Two and 2) offspring outcomes of maternal epilepsy in Chapter Three. These reviews provided unadjusted pooled odds ratios (OR) with 95% confidence intervals (95CI) and highlighted knowledge gaps. A retrospective cohort study was then conducted to investigate the adulthood socioeconomic outcomes in children with and without a history of seizures. This study used regional Scottish data, and while the results are not provided in this abstract, the manuscript is provided in Chapter Four to show the academic and professional developmental throughout this PhD, including applying to regulatory and ethical bodies for data access, and conducting data manipulation and analysis within a Safe Haven setting using relevant statistical software packages. This study provided the technical experience required to conduct a population-based retrospective cohort study using linked routinely collected health data in Scotland (1992-2021) to determine the association between epilepsy in pregnancy and perinatal outcomes and the role of prenatal ASM exposure Chapter Five. The population was identified as all women with at least one pregnancy occurring 1992-2021 in Scotland (1992-2008). Epilepsy was identified using International Classification of Disease codes 9-10. ASM exposure was defined as medications dispensed within the prenatal period. Multi-level multiple binary logistic regressions were conducted to account for covariates and repeated measures; OR and adjusted OR (aOR) with 95CI are provided for perinatal (maternal, foetal, neonatal) outcomes in women with and without epilepsy and all pregnancies with and without prenatal ASM exposure. RESULTS: The two systematic reviews found that maternal epilepsy is associated with increased odds of miscarriage OR 1.62 (95CI 1.15, 2.29), stillbirth 1.37 (1.29, 1.47), preterm birth 1.41 (1.32, 1.51), maternal death 5.00 (1.38, 18.04), offspring congenital conditions 1.88 (1.66, 2.12), neonatal intensive care unit admission 1.99 (1.58, 2.51), neonatal or infant death 1.87 (1.56, 2.24), autism 1.67 (1.54, 1.82), attention-deficit/hyperactivity disorder 1.59 (1.44, 1.76), intellectual disability 2.37 (2.13, 2.65), and having special educational needs 2.60 (1.07, 6.34). The odds of adverse perinatal and offspring outcomes were higher with greater use of ASM, yet analyses were not possible for individual ASMs or potential confounders. In national health data analyses, 931,072 pregnancies occurred 1992-2008 (women with epilepsy (WWE)= 2,014 and women without epilepsy (WWoE)= 929,058) and 629,200 occurred 2009-2021 (WWE=2,022, WWoE=627,178; all pregnancies exposed=4,406 and unexposed to prenatal ASM=624,794). Between 1992-2008, WWE had increased odds of preterm birth 1.48 [1.26, 1.74], induced labour 1.42 [1.28, 1.57], caesarean section 1.34 [1.19, 1.51], eclampsia 11.96 [6.32, 22.61], preeclampsia 1.55 [1.22, 1.98], PPH 1.29 [1.13, 1.47], maternal death 6.47 [2.40, 17.40], offspring neonatal intensive care unit admission 1.84 [1.59, 2.12], offspring congenital conditions 1.60 [1.33, 1.94], low birth weight 1.58 [1.35, 1.86], and Apgar <7 1.54 [1.24, 1.92]. When additionally adjusting for prenatal ASM and other covariates in pregnancies occurring 2009-2021, WWE had increased odds of induced labour aOR 1.17 [1.02, 1.34], and no differences were observed for other outcomes. In all pregnancies occurring 2009-2021, those exposed had increased odds of preterm birth aOR 1.47 [1.25, 1.74], induced labour 1.38 [1.25, 1.52], caesarean section 1.14 [1.01, 1.27], offspring congenital conditions 1.34 [1.04, 1.73], neonatal intensive care unit admission 1.54 [1.33, 1.78], neonatal death 2.53 [1.16, 5.53], and low birth weight 1.41 1.47 [1.23, 1.75]. CONCLUSION: Systematic review and meta-analysis findings indicated that women with epilepsy had increased odds of adverse perinatal and offspring outcomes, and that odds of adverse outcomes are exacerbated by ASM burden. National data studies provide further evidence, suggesting that, although epilepsy is independently associated with increased odds of induced labour, prenatal ASM exposure independently contributes to increased odds of other adverse perinatal outcomes. Comprehensive care from an epilepsy specialist is required, considering both the condition and the potential role of ASMs. Furthermore, the results highlight the need to counsel WWoE who are taking ASMs during the prenatal period, as there is evidence that the risks of adverse outcomes are increased, regardless of epilepsy diagnosis.
Degree
thesis:*- Grantor dc:publisher
- The University of Edinburgh
- Year dc:date.issued
- 2025
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Mazzone, Paolo Pierino
- Advisors dc:contributor.advisor
-
- Chin, Richard
- Stephen, Jacqueline
- Weir, Christopher
Subjects
dc:subject × 7Rights
- Language dc:language.iso
- en
Identifiers
dc:identifier.*- Identifier URI
- http://dx.doi.org/10.7488/era/5510